ABM vs GEV

ABM's Piotroski F-Score of 5/9 indicates a stable but not strong financial health, with no Altman Z-Score available to assess bankruptcy risk. The stock trades at $38.77, significantly above its Graham Number of $41.41 and well below its intrinsic value estimate of $18.13, suggesting overvaluation relative to conservative metrics. Despite a 6.1% YoY revenue growth, earnings have declined by 7.2% YoY, and recent quarters have consistently missed estimates with an average surprise of -12.45%. Insider selling totaling $1.81M in the last six months further undermines confidence, while technical trends remain bearish.

GE Vernova Inc. (GEV) trades at a significant premium to both the industrials sector and its closest peers, with a P/E of 94.34 versus a sector average of 27.54, raising valuation concerns despite strong 5-year price appreciation of +341.7%. The company exhibits solid revenue growth at 11.8% YoY and improving profitability trends, including a ROE of 16.72% and low leverage (Debt/Equity: 0.11), but erratic earnings performance and negative Q/Q EPS growth (-23.7%) undermine confidence in sustained momentum. Analysts are bullish with a $679.30 target price implying ~17% upside, yet insider selling—particularly a $2.05M CFO sale—contradicts this optimism. While financial health is stable and growth fundamentals show promise, stretched valuations and inconsistent earnings delivery create a conflicted outlook, warranting caution despite favorable sector positioning.